Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07556562
What this trial is testing

Early Diagnosis of High-grade Serous Epithelial Ovarian Cancer Through the Analysis of DNA Derived From Pap Test Smear.

Who this might be right for
Germline Mutations
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 260
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Not applicableWithdrawnNCT01703442
What this trial is testing

Intraoperative Anuric Episodes in Patients Undergoing Laparotomy

Who this might be right for
Intraoperative Anuria
Claudia Spies
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Early research (Phase 1)Ended earlyNCT03162562
What this trial is testing

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

Who this might be right for
Cancer of OvaryNeoplasms, OvarianOvarian Cancer Stage IV+3 more
CanariaBio Inc. 10
Not applicableLooking for participantsNCT06036810
What this trial is testing

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 70
Not applicableStudy completedNCT07651020
What this trial is testing

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

Who this might be right for
Pancreatic CancerBreast CancerLung Cancer+6 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1
Testing effectiveness (Phase 2)Study completedNCT01867086
What this trial is testing

Salvage Ovarian FANG™ Vaccine + Carboplatinum

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
Gradalis, Inc. 1
Testing effectiveness (Phase 2)UnknownNCT03899610
What this trial is testing

A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D)

Who this might be right for
Ovarian Cancer Stage IIICOvarian Cancer Stage IV
Yonsei University 24
Not applicableLooking for participantsNCT06726642
What this trial is testing

CfDNA in Hereditary And High-risk Malignancies 2

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,000
Not applicableNot Yet RecruitingNCT07153705
What this trial is testing

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

Who this might be right for
Ovarian Cancer
Beihua Kong 32
Not applicableEnded earlyNCT03128294
What this trial is testing

Long Term Survivors in Ovarian Cancer

Who this might be right for
Ovarian Cancer
University Medical Center Groningen 69
Early research (Phase 1)Study completedNCT02033551
What this trial is testing

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Who this might be right for
Breast CancerOvarian CancerColon Cancer+3 more
AbbVie 47
Testing effectiveness (Phase 2)Study completedNCT00096239
What this trial is testing

CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06892275
What this trial is testing

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Who this might be right for
Breast Neoplasm FemaleEarly Detection of CancerHereditary Breast and Ovarian Cancer Syndrome+1 more
Georgetown University 80
Testing effectiveness (Phase 2)Study completedNCT00504257
What this trial is testing

Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerMalignant Tumor of Peritoneum
H. Lee Moffitt Cancer Center and Research Institute 45
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Looking for participantsNCT05417594
What this trial is testing

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 695
Testing effectiveness (Phase 2)Looking for participantsNCT06840002
What this trial is testing

A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 150
Post-approval studies (Phase 4)WithdrawnNCT02000739
What this trial is testing

Genetically-informed Therapies for Patients With Metastatic Cancer

Who this might be right for
Metastatic Cancer
Dartmouth-Hitchcock Medical Center
Next Page